
Global Fluorescence Cell Market Report and Forecast 2024-2032
Description
Global Fluorescence Cell Market Report and Forecast 2024-2032
Global Fluorescence Cell Market Report and Forecast 2024-2032
Global Fluorescence Cell Market Outlook
The global fluorescence cell market size was valued at USD 724.6 million in 2023, driven by increased demand for new pharmaceuticals across the globe. The market is expected to grow at a CAGR of 6.3% during the forecast period of 2024-2032, with the values likely to rise from USD 770.2 million in 2024 to USD 1255.8 million by 2032.
Fluorescence Cell: Introduction
Fluorescence cell imaging enables scientists to visualize and study cellular processes with exceptional detail and precision. This technology involves the use of fluorescent dyes and probes that emit light of specific wavelengths when excited by light of a different wavelength. With the help of this technique researchers can study numerous cellular components, such as proteins, nucleic acids, and organelles, in real-time and with high sensitivity. Fluorescence cell imaging is widely used in research, diagnostics, and drug development.
Global Fluorescence Cell Market Analysis
The fluorescence cell market demand is driven by the increasing application of advanced imaging techniques in various research areas such as molecular biology, genetics, neuroscience, and drug discovery. Fluorescence cell imaging technique provides researchers with valuable insights into cellular dynamics, protein interactions, and disease mechanisms which helps them develop personalized treatments plans for patients in need.
The market growth can be attributed to growing technical advancements in the microscopy field. In May 2023, the scientists from Max Planck Institute of Biochemistry (MPIB) and Ludwig-Maximilians-Universität (LMU), Munich, developed a technique to improve the fluorescence microscopy resolution. It employs a super-resolution technique called single-molecule localization microscopy (SMLM) to resolve sub cellular structures up to about ten nanometers in size by temporally separating their fluorescence emission.
The fluorescence cell market value is also growing with increasing application in the diagnosis domain. In diagnostics, fluorescence cell imaging helps in the identification and classification of specific biomarkers connected with diseases, helping with accurate diagnosis and personalized treatment decisions. In addition, with increasing integration of artificial intelligence into the medical research ecosystem, a portable AI-enhanced fluorescence microscope that offers real time target detection has also emerged in the market.
Global Fluorescence Cell Market Segmentation
Market Breakup by Material Type
- Optical Glass
- Ultraviolet Quartz
- Infrared Quartz
- 1mm - 2mm
- 5mm - 10mm
- 10mm - 20mm
- 20mm and above
- Biotechnology Companies
- Research Organizations
- Academic Institutes
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America has been the largest fluorescence cell market share holder in recent years. Having pioneering research and academic institutions along with healthcare companies is a factor for the market share. With ongoing technical advancements, the region also boasts a well-structured research infrastructure to adapt to all the latest technologies.
Europe on the other hand has been a major contributor to the market value. The government bodies and authorities promote research activities. In addition, recent mergers and acquisitions also foster innovation.
The Asia-Pacific region is experiencing significant transformation and is projected to witness expediated fluorescence cell market growth in upcoming years. Acknowledging the academic talent and easy availability of resources, several influential MedTech companies are setting up new research labs and working on improving the prevailing system. Emerging economies like India are expected to expand with latest government initiatives. The government of India has launched a campaign to invest INR 5000 crore for developing new pharmaceuticals and drugs. Such initiatives will require improved imaging techniques and impact the fluorescence cell market directly.
Global Fluorescence Cell Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- HORIBA, Ltd.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Oxford Instruments plc
- Bruker Corporation
- Tecan Group Ltd.
- Hitachi, Ltd.
- Carl Zeiss AG
- Hamamatsu Photonics K.K.
- Merck KGaA
- Becton, Dickinson and Company (BD)
- Nikon Corporation
FAQs
- What was the global fluorescence cell market value in 2023?
- What is the global fluorescence cell market forecast outlook for 2024-2032?
- What are the major factors aiding the global fluorescence cell market demand?
- What are the major global fluorescence cell market trends?
- What are the different material types in the fluorescence cell market?
- What are the path lengths present in the market?
- Who are the end users in the market?
- What are the major regional market for fluorescence cells, according to the EMR report?
- Who are the key players involved in the fluorescence cell market?
____________________________________________________________________
Meta description
The global fluorescence cell market size was valued at USD 724.6 million in 2023 and it is anticipated to grow at a CAGR of 6.3% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Fluorescence Cell Market Overview
- 3.1 Global Fluorescence Cell Market Historical Value (2017-2023)
- 3.2 Global Fluorescence Cell Market Forecast Value (2024-2032)
- 4 Global Fluorescence Cell Market Landscape
- 4.1 Global Fluorescence Cell Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Fluorescence Cell Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Path Length
- 5 Global Fluorescence Cell Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Fluorescence Cell Market Segmentation
- 6.1 Global Fluorescence Cell Market by Material Type
- 6.1.1 Market Overview
- 6.1.2 Optical Glass
- 6.1.3 Ultraviolet Quartz
- 6.1.4 Infrared Quartz
- 6.2 Global Fluorescence Cell Market by Path Length
- 6.2.1 Market Overview
- 6.2.2 1mm - 2mm
- 6.2.3 5mm - 10mm
- 6.2.4 10mm - 20mm
- 6.2.5 20mm and above
- 6.3 Global Fluorescence Cell Market by End User
- 6.3.1 Market Overview
- 6.3.2 Biotechnology Companies
- 6.3.3 Research Organizations
- 6.3.4 Academic Institutes
- 6.3.5 Others
- 6.4 Global Fluorescence Cell Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Fluorescence Cell Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Fluorescence Cell Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Fluorescence Cell Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Fluorescence Cell Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Fluorescence Cell Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Thermo Fisher Scientific Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 PerkinElmer Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 HORIBA, Ltd.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Agilent Technologies, Inc.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Bio-Rad Laboratories, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Danaher Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Oxford Instruments plc
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Bruker Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Tecan Group Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Hitachi, Ltd.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Carl Zeiss AG
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Hamamatsu Photonics K.K.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Merck KGaA
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Becton, Dickinson and Company (BD)
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Nikon Corporation
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 18 Global Fluorescence Cell Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.